Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7526)
All Articles published online
|
Sep 14, 2011 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Gu FM, Li QL, Gao Q, Jiang JH, Huang XY, Pan JF, Fan J, Zhou J. Sorafenib inhibits growth and metastasis of hepatocellular carcinoma by blocking STAT3. World J Gastroenterol 2011; 17(34): 3922-3932 [PMID: 22025881 DOI: 10.3748/wjg.v17.i34.3922] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v17/i34/3922.htm |
| Number | Citing Articles |
| 1 |
Renlian Cai, Xumei Chen, Samiullah Khan, Haiyin Li, Jun Tan, Ying Tian, Shuai Zhao, Zhiyong Yin, Daochao Jin, Jianjun Guo. Aspongopus chinensis Dallas induces pro-apoptotic and cell cycle arresting effects in hepatocellular carcinoma cells by modulating miRNA and mRNA expression. Heliyon 2024; 10(6): e27525 doi: 10.1016/j.heliyon.2024.e27525
|
| 2 |
Jasmin Svinka, Wolfgang Mikulits, Robert Eferl. STAT3 in hepatocellular carcinoma: new perspectives. Hepatic Oncology 2014; 1(1): 107 doi: 10.2217/hep.13.7
|
| 3 |
L A Walsh, D M Roy, M Reyngold, D Giri, A Snyder, S Turcan, C R Badwe, J Lyman, J Bromberg, T A King, T A Chan. RECK controls breast cancer metastasis by modulating a convergent, STAT3-dependent neoangiogenic switch. Oncogene 2015; 34(17): 2189 doi: 10.1038/onc.2014.175
|
| 4 |
Vichununt Kerdput, Cheng Nilbu-nga, Nattpawit Kaewnoonual, Arunporn Itharat, Suriya Pongsawat, Wisuit Pradidarcheep. Therapeutic efficacy of a Dioscorea membranacea extract in a rat model of hepatocellular carcinoma: Histopathological aspects. Journal of Traditional and Complementary Medicine 2021; 11(5): 400 doi: 10.1016/j.jtcme.2021.02.001
|
| 5 |
Rajagopal N. Aravalli, Erik N. K. Cressman, Clifford J. Steer. Cellular and molecular mechanisms of hepatocellular carcinoma: an update. Archives of Toxicology 2013; 87(2): 227 doi: 10.1007/s00204-012-0931-2
|
| 6 |
Quan-Lin Li, Fang-Ming Gu, Zheng Wang, Jia-Hao Jiang, Li-Qing Yao, Chang-Jun Tan, Xiao-Yong Huang, Ai-Wu Ke, Zhi Dai, Jia Fan, Jian Zhou, Xin-yuan Guan. Activation of PI3K/AKT and MAPK Pathway through a PDGFRβ-Dependent Feedback Loop Is Involved in Rapamycin Resistance in Hepatocellular Carcinoma. PLoS ONE 2012; 7(3): e33379 doi: 10.1371/journal.pone.0033379
|
| 7 |
Ryan B Perumpail, Andy Liu, Robert J Wong, Aijaz Ahmed, Stephen A Harrison. Pathogenesis of hepatocarcinogenesis in non-cirrhotic nonalcoholic fatty liver disease: Potential mechanistic pathways. World Journal of Hepatology 2015; 7(22): 2384-2388 doi: 10.4254/wjh.v7.i22.2384
|
| 8 |
ROBIN J. YOUNG, MALCOLM W.R. REED. Anti‐angiogenic Therapy: Concept to Clinic. Microcirculation 2012; 19(2): 115 doi: 10.1111/j.1549-8719.2011.00147.x
|
| 9 |
Yuchuan Jiang, Peng Chen, Kaishun Hu, Guanqi Dai, Jinying Li, Dandan Zheng, Hui Yuan, Lu He, Penghui Xie, Mengxian Tu, Shuang Peng, Chen Qu, Wenyu Lin, Raymond T. Chung, Jian Hong. Inflammatory microenvironment of fibrotic liver promotes hepatocellular carcinoma growth, metastasis and sorafenib resistance through STAT3 activation. Journal of Cellular and Molecular Medicine 2021; 25(3): 1568 doi: 10.1111/jcmm.16256
|
| 10 |
P. S. Demenkov, E. A. Antropova, A. V. Adamovskaya, E. I. Mishchenko, T. M. Khlebodarova, T. V. Ivanisenko, N. V. Ivanisenko, A. S. Venzel, I. N. Lavrik, V. A. Ivanisenko. Prioritization of potential pharmacological targets for the development of anti-hepatocarcinoma drugs modulating the extrinsic apoptosis pathway: the reconstruction and analysis of associative gene networks help. Vavilov Journal of Genetics and Breeding 2023; 27(7): 784 doi: 10.18699/VJGB-23-91
|
| 11 |
Mustafa A. Barbhuiya, Adam C. Mirando, Brian W. Simons, Ghali Lemtiri-Chlieh, Jordan J. Green, Aleksander S. Popel, Niranjan B. Pandey, Phuoc T. Tran. Therapeutic potential of an anti-angiogenic multimodal biomimetic peptide in hepatocellular carcinoma. Oncotarget 2017; 8(60): 101520 doi: 10.18632/oncotarget.21148
|
| 12 |
Paloma Sangro, Idoia Bilbao, Nerea Fernández-Ros, Mercedes Iñarrairaegui, Javier Zulueta, JI Bilbao, Bruno Sangro. Pneumatocele during sorafenib therapy: first report of an unusual complication. Oncotarget 2018; 9(5): 6652 doi: 10.18632/oncotarget.23599
|
| 13 |
Shujie Hou, Yong Weon Yi, Hyo Jin Kang, Li Zhang, Hee Jeong Kim, Yali Kong, Yong Liu, Kan Wang, Hye-Sik Kong, Scott Grindrod, Insoo Bae, Milton L. Brown. Novel Carbazole Inhibits Phospho-STAT3 through Induction of Protein–Tyrosine Phosphatase PTPN6. Journal of Medicinal Chemistry 2014; 57(15): 6342 doi: 10.1021/jm4018042
|
| 14 |
Jaleh Varshosaz, Farzaneh Sadri, Mahboubeh Rostami, Mina Mirian, Somayeh Taymouri. Synthesis of pectin-deoxycholic acid conjugate for targeted delivery of anticancer drugs in hepatocellular carcinoma. International Journal of Biological Macromolecules 2019; 139: 665 doi: 10.1016/j.ijbiomac.2019.07.225
|
| 15 |
Antonio Lavecchia, Carmen Di Giovanni, Carmen Cerchia. Novel inhibitors of signal transducer and activator of transcription 3 signaling pathway: an update on the recent patent literature. Expert Opinion on Therapeutic Patents 2014; 24(4): 383 doi: 10.1517/13543776.2014.877443
|
| 16 |
Rita Dornetshuber-Fleiss, Daniela Heilos, Thomas Mohr, Lennart Richter, Roderich D. Süssmuth, Markus Zlesak, Astrid Novicky, Petra Heffeter, Rosa Lemmens-Gruber, Walter Berger. The naturally born fusariotoxin enniatin B and sorafenib exert synergistic activity against cervical cancer in vitro and in vivo. Biochemical Pharmacology 2015; 93(3): 318 doi: 10.1016/j.bcp.2014.12.013
|
| 17 |
Jian-Ji Li, Zhe Yang, Zan-Song Huang. Progress in basic and clinical research on molecular targeted therapy for primary hepatic carcinoma. World Chinese Journal of Digestology 2019; 27(10): 643 doi: 10.11569/wcjd.v27.i10.643
|
| 18 |
Weinire Abuduwaili, Xiang Wang, An-Tian Huang, Jia-Lei Sun, Ru-Chen Xu, Guang-Cong Zhang, Zhi-Yong Liu, Fu Wang, Chang-Feng Zhu, Tao-Tao Liu, Ling Dong, Ji-Min Zhu, Shu-Qiang Weng, Yuhao Li, Xi-Zhong Shen. Iridium Complex-Loaded Sorafenib Nanocomposites for Synergistic Chemo-photodynamic Therapy of Hepatocellular Carcinoma. ACS Applied Materials & Interfaces 2022; 14(33): 37356 doi: 10.1021/acsami.2c07247
|
| 19 |
María Luz Morales, Alicia Arenas, Alejandra Ortiz-Ruiz, Alejandra Leivas, Inmaculada Rapado, Alba Rodríguez-García, Nerea Castro, Ivana Zagorac, Miguel Quintela-Fandino, Gonzalo Gómez-López, Miguel Gallardo, Rosa Ayala, María Linares, Joaquín Martínez-López. MEK inhibition enhances the response to tyrosine kinase inhibitors in acute myeloid leukemia. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-54901-9
|
| 20 |
Hyun-Ju Yu, Ji-Ae Shin, Ji-Youn Jung, Jeong-Seok Nam, In-Sun Hong, Nam-Pyo Cho, Sung-Dae Cho. Inhibition of myeloid cell leukemia-1: Association with sorafenib-induced apoptosis in human mucoepidermoid carcinoma cells and tumor xenograft. Head & Neck 2015; 37(9): 1326 doi: 10.1002/hed.23749
|
| 21 |
Aruljothi Subramaniam, Muthu K. Shanmugam, Ekambaram Perumal, Feng Li, Alamelu Nachiyappan, Xiaoyun Dai, Shivananju Nanjunda Swamy, Kwang Seok Ahn, Alan Prem Kumar, Benny K.H. Tan, Kam Man Hui, Gautam Sethi. Potential role of signal transducer and activator of transcription (STAT)3 signaling pathway in inflammation, survival, proliferation and invasion of hepatocellular carcinoma. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2013; 1835(1): 46 doi: 10.1016/j.bbcan.2012.10.002
|
| 22 |
Yasunari Nakamoto. Promising new strategies for hepatocellular carcinoma. Hepatology Research 2017; 47(4): 251 doi: 10.1111/hepr.12795
|
| 23 |
George Denis Alexandru Popescu, Cristian Scheau, Ioana Anca Badarau, Mihai-Daniel Dumitrache, Ana Caruntu, Andreea-Elena Scheau, Daniel Octavian Costache, Raluca Simona Costache, Carolina Constantin, Monica Neagu, Constantin Caruntu. The Effects of Capsaicin on Gastrointestinal Cancers. Molecules 2020; 26(1): 94 doi: 10.3390/molecules26010094
|
| 24 |
Yongjing Zhang, Zhuoyin Xue, Shiling Hu, Haoyun Bai, Jue Wang, Nan Wang. Chrysin Inhibits Pseudo-allergic Reaction by Suppressing Mitochondrial STAT3 Activation via MAS-Related GPR Family Member X2. Journal of Agricultural and Food Chemistry 2021; 69(23): 6569 doi: 10.1021/acs.jafc.1c02565
|
| 25 |
Stefan Weigand, Frank Herting, Daniela Maisel, Adam Nopora, Edgar Voss, Christoph Schaab, Martin Klammer, Andreas Tebbe. Global Quantitative Phosphoproteome Analysis of Human Tumor Xenografts Treated with a CD44 Antagonist. Cancer Research 2012; 72(17): 4329 doi: 10.1158/0008-5472.CAN-12-0136
|
| 26 |
Hyun-Seuk Moon, Maria Dalamaga, Sang-Yong Kim, Stergios A. Polyzos, Ole-Petter Hamnvik, Faidon Magkos, Jason Paruthi, Christos S. Mantzoros. Leptin's Role in Lipodystrophic and Nonlipodystrophic Insulin-Resistant and Diabetic Individuals. Endocrine Reviews 2013; 34(3): 377 doi: 10.1210/er.2012-1053
|
| 27 |
Ruyin Chen, Qiong Li, Shuaishuai Xu, Chanqi Ye, Tian Tian, Qi Jiang, Jianzhen Shan, Jian Ruan. Modulation of the tumour microenvironment in hepatocellular carcinoma by tyrosine kinase inhibitors: from modulation to combination therapy targeting the microenvironment. Cancer Cell International 2022; 22(1) doi: 10.1186/s12935-021-02435-4
|
| 28 |
Ping Yi, Arisa Higa, Said Taouji, Mariana G. Bexiga, Esther Marza, Daniela Arma, Claire Castain, Brigitte Le Bail, Jeremy C. Simpson, Jean Rosenbaum, Charles Balabaud, Paulette Bioulac-Sage, Jean-Frédéric Blanc, Eric Chevet. Sorafenib-Mediated Targeting of the AAA+ ATPase p97/VCP Leads to Disruption of the Secretory Pathway, Endoplasmic Reticulum Stress, and Hepatocellular Cancer Cell Death. Molecular Cancer Therapeutics 2012; 11(12): 2610 doi: 10.1158/1535-7163.MCT-12-0516
|
| 29 |
Tohid Gharibi, Zohreh Babaloo, Arezoo Hosseini, Meghdad Abdollahpour-alitappeh, Vida Hashemi, Faroogh Marofi, Kazem Nejati, Behzad Baradaran. Targeting STAT3 in cancer and autoimmune diseases. European Journal of Pharmacology 2020; 878: 173107 doi: 10.1016/j.ejphar.2020.173107
|
| 30 |
Constanze Mittermeier, Andreas Konopa, Susanne Muehlich. Molecular Mechanisms to Target Cellular Senescence in Hepatocellular Carcinoma. Cells 2020; 9(12): 2540 doi: 10.3390/cells9122540
|
| 31 |
Tasuku Nagasawa, Md Abdul Hye Khan, John D Imig. Captopril attenuates hypertension and renal injury induced by the vascular endothelial growth factor inhibitor sorafenib. Clinical and Experimental Pharmacology and Physiology 2012; 39(5): 454 doi: 10.1111/j.1440-1681.2012.05699.x
|
| 32 |
Bo Zhai, Xue-Ying Sun. Mechanisms of resistance to sorafenib and the corresponding strategies in hepatocellular carcinoma. World Journal of Hepatology 2013; 5(7): 345-352 doi: 10.4254/wjh.v5.i7.345
|
| 33 |
Weibo Chen, Junhua Wu, Hua Shi, Zhongxia Wang, Guang Zhang, Yin Cao, Chunping Jiang, Yitao Ding. Hepatic Stellate Cell Coculture Enables Sorafenib Resistance in Huh7 Cells through HGF/c-Met/Akt and Jak2/Stat3 Pathways. BioMed Research International 2014; 2014: 1 doi: 10.1155/2014/764981
|
| 34 |
J C Roeser, S D Leach, F McAllister. Emerging strategies for cancer immunoprevention. Oncogene 2015; 34(50): 6029 doi: 10.1038/onc.2015.98
|
| 35 |
SEN LU, YUN GAO, XINLI HUANG, XUEHAO WANG. GYY4137, a hydrogen sulfide (H2S) donor, shows potent anti-hepatocellular carcinoma activity through blocking the STAT3 pathway. International Journal of Oncology 2014; 44(4): 1259 doi: 10.3892/ijo.2014.2305
|
| 36 |
Fatty Acid Esters of Phloridzin Induce Apoptosis of Human Liver Cancer Cells through Altered Gene Expression. PLoS ONE 2014; 9(9): e107149 doi: 10.1371/journal.pone.0107149
|
| 37 |
Nina M. Muñoz, Adeeb A. Minhaj, Kiersten L. Maldonado, Charles V. Kingsley, Andrea C. Cortes, Houra Taghavi, Urszula Polak, Jennifer M. Mitchell, Joe E. Ensor, James A. Bankson, Asif Rashid, Rony Avritscher. Comparison of dynamic contrast-enhanced magnetic resonance imaging and contrast-enhanced ultrasound for evaluation of the effects of sorafenib in a rat model of hepatocellular carcinoma. Magnetic Resonance Imaging 2019; 57: 156 doi: 10.1016/j.mri.2018.11.012
|
| 38 |
Laura Rosenberg, Charles H Yoon, Gaurav Sharma, Monica M Bertagnolli, Nancy L Cho. Sorafenib inhibits proliferation and invasion in desmoid-derived cells by targeting Ras/MEK/ERK and PI3K/Akt/mTOR pathways. Carcinogenesis 2018; 39(5): 681 doi: 10.1093/carcin/bgy038
|
| 39 |
Ryota Kondo, Kousuke Ishino, Ryuichi Wada, Hideyuki Takata, Wei‑Xia Peng, Mitsuhiro Kudo, Shoko Kure, Yohei Kaneya, Nobuhiko Taniai, Hiroshi Yoshida, Zenya Naito. Downregulation of protein disulfide‑isomerase A3 expression inhibits cell proliferation and induces apoptosis through STAT3 signaling in hepatocellular carcinoma. International Journal of Oncology 2019; doi: 10.3892/ijo.2019.4710
|
| 40 |
Gaël S. Roth, Zuzana Macek Jilkova, Ayca Zeybek Kuyucu, Keerthi Kurma, Séyédéh Tayébéh Ahmad Pour, Giovanni Abbadessa, Yi Yu, Benoit Busser, Patrice N. Marche, Vincent Leroy, Thomas Decaens. Efficacy of AKT Inhibitor ARQ 092 Compared with Sorafenib in a Cirrhotic Rat Model with Hepatocellular Carcinoma. Molecular Cancer Therapeutics 2017; 16(10): 2157 doi: 10.1158/1535-7163.MCT-16-0602-T
|
| 41 |
Jian Kong, Fandong Kong, Jun Gao, Qiangbo Zhang, Shuying Dong, Fang Gu, Shan Ke, Bing Pan, Qiang Shen, Huichuan Sun, Lemin Zheng, Wenbing Sun. YC-1 enhances the anti-tumor activity of sorafenib through inhibition of signal transducer and activator of transcription 3 (STAT3) in hepatocellular carcinoma. Molecular Cancer 2014; 13(1) doi: 10.1186/1476-4598-13-7
|
| 42 |
Myoung Ok Kim, Mee-Hyun Lee, Naomi Oi, Sung-Hyun Kim, Ki Beom Bae, Zunnan Huang, Dong Joon Kim, Kanamata Reddy, Sung-Young Lee, Si Jun Park, Jae Young Kim, Hua Xie, Joydeb Kumar Kundu, Zae Young Ryoo, Ann M. Bode, Young-Joon Surh, Zigang Dong. [6]-Shogaol inhibits growth and induces apoptosis of non-small cell lung cancer cells by directly regulating Akt1/2. Carcinogenesis 2014; 35(3): 683 doi: 10.1093/carcin/bgt365
|
| 43 |
Ting-Yi Tien, Yih-Jer Wu, Cheng-Huang Su, Chin-Ling Hsieh, Bo-Jeng Wang, Yi-Nan Lee, Yeu Su, Hung-I Yeh. Pannexin 1 Modulates Angiogenic Activities of Human Endothelial Colony-Forming Cells Through IGF-1 Mechanism and Is a Marker of Senescence. Arteriosclerosis, Thrombosis, and Vascular Biology 2023; 43(10): 1935 doi: 10.1161/ATVBAHA.123.319529
|
| 44 |
WEI ZHANG, SONGYANG LIU, KAI LIU, BAI JI, YINGCHAO WANG, YAHUI LIU. Knockout of ADAM10 enhances sorafenib antitumor activity of hepatocellular carcinoma in vitro and in vivo. Oncology Reports 2014; 32(5): 1913 doi: 10.3892/or.2014.3418
|
| 45 |
Vinit Singh Baghel, Sapnita Shinde, Vineeta Dixit, Naveen Kumar Vishvakarma, Atul Kumar Tiwari, Soumitra Tiwari, Dhananjay Shukla. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 2. 2022; : 337 doi: 10.1016/B978-0-323-98807-0.00009-0
|
| 46 |
Xiaokang Shi, Bin Wang, Xiaoyan Chen, Yuyang Zheng, Youming Ding, Changhua Wang. Upregulation of ubiquitin-conjugating enzyme E2Z is associated with human hepatocellular carcinoma. Biochemical and Biophysical Research Communications 2020; 523(1): 25 doi: 10.1016/j.bbrc.2019.11.170
|
| 47 |
S Marozin, J Altomonte, K A Muñoz-Álvarez, A Rizzani, E N De Toni, W E Thasler, R M Schmid, O Ebert. STAT3 inhibition reduces toxicity of oncolytic VSV and provides a potentially synergistic combination therapy for hepatocellular carcinoma. Cancer Gene Therapy 2015; 22(6): 317 doi: 10.1038/cgt.2015.23
|
| 48 |
Zhen Han, Shuo Liu, Hongsheng Lin, Anna L. Trivett, Sean Hannifin, De Yang, Joost J. Oppenheim. Inhibition of murine hepatoma tumor growth by cryptotanshinone involves TLR7-dependent activation of macrophages and induction of adaptive antitumor immune defenses. Cancer Immunology, Immunotherapy 2019; 68(7): 1073 doi: 10.1007/s00262-019-02338-4
|
| 49 |
Jie Yang, Xueting Cai, Wuguang Lu, Chunping Hu, Xiaojun Xu, Qiang Yu, Peng Cao. Evodiamine inhibits STAT3 signaling by inducing phosphatase shatterproof 1 in hepatocellular carcinoma cells. Cancer Letters 2013; 328(2): 243 doi: 10.1016/j.canlet.2012.09.019
|
| 50 |
Xuying Wan, Xiaofeng Zhai, Zhenlin Yan, Pinghua Yang, Jun Li, Dong Wu, Kui Wang, Yong Xia, Feng Shen. Retrospective analysis of transarterial chemoembolization and sorafenib in Chinese patients with unresectable and recurrent hepatocellular carcinoma. Oncotarget 2016; 7(50): 83806 doi: 10.18632/oncotarget.11514
|
| 51 |
Xiaoli Wang, Hua Li, Dong Li, Yudi Bai, Yao Zhang, Xue Yan, Jin Li, Ri Zhao, Jiahui Liu, Wei Liu, Maolin Shi, Cheng Xu, Tai Yang, Tao Zhang. Sorafenib and CuB exert synergistic antitumor effects against hepatocellular carcinoma cells via inhibition of STAT3 phosphorylation. FEBS Open Bio 2021; 11(1): 133 doi: 10.1002/2211-5463.13035
|
| 52 |
Malabika Sen, Sufi M. Thomas, Seungwon Kim, Joanne I. Yeh, Robert L. Ferris, Jonas T. Johnson, Umamaheswar Duvvuri, Jessica Lee, Nivedita Sahu, Sonali Joyce, Maria L. Freilino, Haibin Shi, Changyou Li, Danith Ly, Srinivas Rapireddy, Jonathan P. Etter, Pui-Kai Li, Lin Wang, Simion Chiosea, Raja R. Seethala, William E. Gooding, Xiaomin Chen, Naftali Kaminski, Kusum Pandit, Daniel E. Johnson, Jennifer R. Grandis. First-in-Human Trial of a STAT3 Decoy Oligonucleotide in Head and Neck Tumors: Implications for Cancer Therapy. Cancer Discovery 2012; 2(8): 694 doi: 10.1158/2159-8290.CD-12-0191
|
| 53 |
Syamantak Majumder, Anne-Christine Piguet, Jean-François Dufour, Suvro Chatterjee. Study of the cellular mechanism of Sunitinib mediated inactivation of activated hepatic stellate cells and its implications in angiogenesis. European Journal of Pharmacology 2013; 705(1-3): 86 doi: 10.1016/j.ejphar.2013.02.026
|
| 54 |
Agostina Grillone, Eugenio Redolfi Riva, Alessio Mondini, Claudia Forte, Lucia Calucci, Claudia Innocenti, Cesar de Julian Fernandez, Valentina Cappello, Mauro Gemmi, Stefania Moscato, Francesca Ronca, Rodolfo Sacco, Virgilio Mattoli, Gianni Ciofani. Active Targeting of Sorafenib: Preparation, Characterization, and In Vitro Testing of Drug‐Loaded Magnetic Solid Lipid Nanoparticles. Advanced Healthcare Materials 2015; 4(11): 1681 doi: 10.1002/adhm.201500235
|
| 55 |
Heba A. Metwaly, Amal M. El-Gayar, Mamdouh M. El-Shishtawy. Inhibition of the signaling pathway of syndecan-1 by synstatin: A promising anti-integrin inhibitor of angiogenesis and proliferation in HCC in rats. Archives of Biochemistry and Biophysics 2018; 652: 50 doi: 10.1016/j.abb.2018.06.007
|
| 56 |
Anne Trécul, Franck Morceau, Anthoula Gaigneaux, Marion Orsini, Sébastien Chateauvieux, Cindy Grandjenette, Mario Dicato, Marc Diederich. Polyphenol tri-vanillic ester 13c inhibits P-JAK2V617F and Bcr–Abl oncokinase expression in correlation with STAT3/STAT5 inactivation and apoptosis induction in human leukemia cells. Cancer Letters 2013; 340(1): 30 doi: 10.1016/j.canlet.2013.06.023
|
| 57 |
Ryan B. Perumpail, Robert J. Wong, Aijaz Ahmed, Stephen A. Harrison. Hepatocellular Carcinoma in the Setting of Non-cirrhotic Nonalcoholic Fatty Liver Disease and the Metabolic Syndrome: US Experience. Digestive Diseases and Sciences 2015; 60(10): 3142 doi: 10.1007/s10620-015-3821-7
|
| 58 |
Seulki Lee, Young Cho, Eun Cho, Su Yu, Jeong‑Hoon Lee, Jung‑Hwan Yoon, Yoon Kim. Synergistic effect of ursodeoxycholic acid on the antitumor activity of sorafenib in hepatocellular carcinoma cells via modulation of STAT3 and ERK. International Journal of Molecular Medicine 2018; doi: 10.3892/ijmm.2018.3807
|
| 59 |
Hong-wei Chen, A-ling Shen, Li-ya Liu, Jun Peng, Jian-feng Chu. Bear Bile Powder Inhibits Growth of Hepatocellular Carcinoma via Suppressing STAT3 Signaling Pathway in Mice. Chinese Journal of Integrative Medicine 2020; 26(5): 370 doi: 10.1007/s11655-019-3010-1
|
| 60 |
Rajagopal N. Aravalli, Clifford J. Steer. Hepatocellular Carcinoma. 2014; : 51 doi: 10.1007/978-3-319-09414-4_7
|
| 61 |
Lifen Deng, Zhenggang Ren, Qingan Jia, Weizhong Wu, Hujia Shen, Yanhong Wang. Schedule-dependent antitumor effects of 5-fluorouracil combined with sorafenib in hepatocellular carcinoma. BMC Cancer 2013; 13(1) doi: 10.1186/1471-2407-13-363
|
| 62 |
Huan Gao, Yuansong Bai, Yuanyuan Jia, Yanan Zhao, Rui Kang, Daolin Tang, Enyong Dai. Ferroptosis is a lysosomal cell death process. Biochemical and Biophysical Research Communications 2018; 503(3): 1550 doi: 10.1016/j.bbrc.2018.07.078
|
| 63 |
Meng Niu, Duo Hong, Teng-Chuang Ma, Xiao-Wei Chen, Jin-Hang Han, Jun Sun, Ke Xu. Short-term and long-term efficacy of 7 targeted therapies for the treatment of advanced hepatocellular carcinoma. Medicine 2016; 95(49): e5591 doi: 10.1097/MD.0000000000005591
|
| 64 |
Chang Li, Xunzhe Yin, Zuojia Liu, Jin Wang. Emerging Potential Mechanism and Therapeutic Target of Ferroptosis in PDAC: A Promising Future. International Journal of Molecular Sciences 2022; 23(23): 15031 doi: 10.3390/ijms232315031
|